Traws Pharma, Inc. (TRAW) SEC Filings — 2024
27 SEC filings for Traws Pharma, Inc. (TRAW) in 2024.
Filings
- Traws Pharma Files 8-K: Agreements, Equity Sales Reported — 8-K · Dec 31, 2024
- Traws Pharma Shuffles Leadership, Appoints New Directors — 8-K · Dec 20, 2024
- Traws Pharma Faces Delisting Concerns — 8-K · Nov 22, 2024
- Traws Pharma Files 8-K on Financials — 8-K · Nov 14, 2024
- Traws Pharma Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
- OrbiMed Amends Traws Pharma Stake Filing — SC 13D/A · Nov 6, 2024
- Traws Pharma Files 8-K on Shareholder Votes & Other Events — 8-K · Nov 1, 2024
- Traws Pharma Files Definitive Proxy Statement — DEF 14A · Oct 11, 2024
- Traws Pharma Faces Delisting Concerns — 8-K · Sep 27, 2024
- OrbiMed Files 13D on Traws Pharma — SC 13D · Sep 23, 2024
- Traws Pharma Reports Director Changes & Shareholder Votes — 8-K · Sep 17, 2024
- Traws Pharma Faces Nasdaq Delisting, Seeks Compliance — 8-K · Aug 23, 2024
- Traws Pharma Files 8-K on Financials — 8-K · Aug 15, 2024
- Traws Pharma Files Q2 2024 10-Q — 10-Q · Aug 15, 2024
- Traws Pharma Files Amended Proxy Statement — DEF 14A · Aug 9, 2024
- Traws Pharma Appoints BDO USA as New Auditor — 8-K · Jul 19, 2024
- Traws Pharma Changes Fiscal Year End — 8-K · Jun 28, 2024
- Traws Pharma Appoints New Director — 8-K · Jun 21, 2024
- Traws Pharma Files 8-K/A Amendment — 8-K/A · Jun 17, 2024
- Traws Pharma Changes Certifying Accountant — 8-K · May 22, 2024
- Traws Pharma Files 8-K on Operations — 8-K · May 16, 2024
- Traws Pharma, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 15, 2024
- Traws Pharma Files 2023 Annual Report Amendment — 10-K/A · Apr 29, 2024
- Traws Pharma Files 8-K for Disclosure and Exhibits — 8-K · Apr 16, 2024
- Viriom, Inc. Discloses Stake in Traws Pharma — SC 13D · Apr 8, 2024
- Traws Pharma Acquires 03 Life Sciences, Names New CMO — 8-K · Apr 4, 2024
- Onconova Therapeutics, Inc. Files 2023 Annual Report (10-K) — 10-K · Apr 1, 2024